Literature DB >> 16404564

Rheumatic diseases and chronic myelogenous leukemia, presentation of four cases and review of the literature.

Soner Senel1, Emin Kaya, Ismet Aydogdu, M Ali Erkurt, Irfan Kuku.   

Abstract

We report four patients with rheumatic disease (RD) and chronic myelogenous leukemia (CML). In two patients with Behcet's disease (BD) and rheumatoid arthritis (RA), CML developed after RD, in two patients with diffuse cutaneous systemic sclerosis and spondyloarthropathy, RD was diagnosed after CML. A variety of interactions have been described between hematological malignancies and RD. Nevertheless, few cases of RD have been documented associated with CML. It is unclear whether the development of CML in patients with RD and RD development after CML occurs by chance alone, is due to the underlying disease, or is facilitated by drugs. Whatever the cause is, it should be kept in mind that CML may develop in the course of RD and RD may be seen in CML patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16404564     DOI: 10.1007/s00296-005-0100-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  25 in total

Review 1.  Spondyloarthropathies.

Authors:  Rajesh K Kataria; Lawrence H Brent
Journal:  Am Fam Physician       Date:  2004-06-15       Impact factor: 3.292

2.  Methotrexate induced lymphoma?

Authors:  W A Bleyer
Journal:  J Rheumatol       Date:  1998-03       Impact factor: 4.666

3.  Behçet's disease in patients with chronic myelogenous leukemia: possible role of interferon-alpha treatment in the occurrence of Behçet's symptoms.

Authors:  T Budak-Alpdoğan; Z Demirçay; O Alpdoğan; H Direskeneli; T Ergun; M Bayik; T Akoğlu
Journal:  Ann Hematol       Date:  1997-01       Impact factor: 3.673

Review 4.  Chronic myelogenous leukemia and porphyria cutanea tarda in a patient with limited systemic sclerosis.

Authors:  M D Wooten; J W Scott; A M Miller; E Boh
Journal:  South Med J       Date:  1998-05       Impact factor: 0.954

5.  [Rheumatoid polyarthritis, Gougerot-Sjögren syndrome and chronic myeloid leukemia. Apropos of 2 cases].

Authors:  C Job-Deslandre; C J Menkès; B Michalski; F Tessier
Journal:  Rev Rhum Mal Osteoartic       Date:  1985-04

Review 6.  Lymphoma in patients with rheumatoid arthritis: association with the disease state or methotrexate treatment.

Authors:  L Georgescu; G C Quinn; S Schwartzman; S A Paget
Journal:  Semin Arthritis Rheum       Date:  1997-06       Impact factor: 5.532

7.  Risk of malignancy among patients with rheumatic conditions.

Authors:  E Thomas; D H Brewster; R J Black; G J Macfarlane
Journal:  Int J Cancer       Date:  2000-11-01       Impact factor: 7.396

8.  The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy.

Authors:  M Dougados; S van der Linden; R Juhlin; B Huitfeldt; B Amor; A Calin; A Cats; B Dijkmans; I Olivieri; G Pasero
Journal:  Arthritis Rheum       Date:  1991-10

9.  Occurrence of neoplasia in patients with rheumatoid arthritis enrolled in a DMARD Registry. Rheumatoid Arthritis Azathioprine Registry Steering Committee.

Authors:  E L Matteson; A R Hickey; L Maguire; H H Tilson; M B Urowitz
Journal:  J Rheumatol       Date:  1991-06       Impact factor: 4.666

10.  Acute leukemia after low dose methotrexate therapy in a patient with rheumatoid arthritis.

Authors:  P Pointud; M Prudat; J M Peron
Journal:  J Rheumatol       Date:  1993-07       Impact factor: 4.666

View more
  4 in total

Review 1.  Rheumatologic manifestations of benign and malignant haematological disorders.

Authors:  Vinod Ravindran; Parameswaran Anoop
Journal:  Clin Rheumatol       Date:  2011-06-23       Impact factor: 2.980

Review 2.  Acute myeloid leukemia developing in patients with autoimmune diseases.

Authors:  Safaa M Ramadan; Tamer M Fouad; Valentina Summa; Syed Kh Hasan; Francesco Lo-Coco
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

3.  Chronic myeloid leukemia following repeated diagnostic X-ray exposure for the treatment of recurrent spontaneous pneumothorax in a patient with ankylosing spondylitis: A case report and literature review.

Authors:  Fang-He Ju; Xu-Bo Gong; Ting-Zhen Xu; Li-Bin Jiang; Hui-Hua Hong; Zhen Wang
Journal:  Oncol Lett       Date:  2017-10-10       Impact factor: 2.967

4.  Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature.

Authors:  M Colaci; D Giuggioli; C Vacchi; C Ferri
Journal:  Case Rep Rheumatol       Date:  2017-05-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.